Phase 3 Nexavar DECISION trial has demonstrated the improvement in progression-free survival in radioactive iodine refractory differentiated thyroid cancer patients. Bayer HealthCare global clinical development oncology vice president
The facility will be constructed by renovating an existing 18,000ft² light manufacturing plant on a 4.2 acre in Shelton, US. Id3A will design the overall facility as well
The trial that is being conducted at City of Hope Comprehensive Cancer Center, will assess the activity of CRLX101 in HER-2 negative gastric cancer patients with progressed disease
Under the purchase agreement, Maine will manufacture, market, sell and distribute laboratory products such as microbiological monitors in both 47mm and 56mm sizes, ready-to-use liquid growth media as
The Ginshen Wubao supplement contains extracts from American Ginseng, which can tonify Qi and Ying, as well as Fo-Ti roots, which can nourish hepatorenal functions, strengthen physique and
The company said that it is working in close alliance with local authorities to secure approval at the quickest time. China Biologic, which had planned to begin preparation
Sanofi Pasteur is expected to leverage Sutro’s cell-free protein synthesis technology in the production of two vaccine candidates. Sutro Biopharma chief executive officer William Newell said the collaboration
Rebif Rebidose was designed as single-use auto-injector for the self-administration of Rebif, a disease-modifying drug. The company anticipates making the product available in a monthly pack in 22
The company obtained market exclusivity for 180 days for Finasteride 1mg tablets in the country. Finasteride tablet is the bioequivalent generic version of Propecia tablets, a prescription medicine
The solution includes new functionality including a rich multi-site architecture which facilitates trial/study set up by therapeutic area, program, partner such as CRO and other configurable attributes. The
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.